OBJECTIVE: To synthesize the existing literature on benefits and risks of anticoagulant use after traumatic brain injury (TBI). DESIGN: Systematic review. A literature search was performed in MEDLINE, International Pharmaceutical Abstracts, Health Star, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) on October 11, 2012, and updated on September 2, 2013, using terms related to TBI and anticoagulants. MAIN MEASURES: Human studies evaluating the effects of post-TBI anticoagulation on venous thromboembolism, hemorrhage, mortality, or coagulation parameters with original analyses were eligible for the review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline was followed throughout the conduct of the review. RESULTS: Thirty-nine eligible studies were identified from the literature, of which 23 studies with complete information on post-TBI anticoagulant use and patient outcomes were summarized in this review. Meta-analysis was unwarranted because of varying methodological design and quality of the studies. Twenty-one studies focused on the effects of pharmacological thromboprophylaxis (PTP) post-TBI on venous thromboembolism and/or progression of intracranial hemorrhage, whereas 2 randomized controlled trials analyzed coagulation parameters as the result of anticoagulation. CONCLUSION: Pharmacological thromboprophylaxis appears to be safe among TBI patients with stabilized hemorrhagic patterns. More evidence is needed regarding effectiveness of PTP in preventing venous thromboembolism as well as preferred agent, dose, and timing for PTP.
OBJECTIVE: To synthesize the existing literature on benefits and risks of anticoagulant use after traumatic brain injury (TBI). DESIGN: Systematic review. A literature search was performed in MEDLINE, International Pharmaceutical Abstracts, Health Star, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) on October 11, 2012, and updated on September 2, 2013, using terms related to TBI and anticoagulants. MAIN MEASURES: Human studies evaluating the effects of post-TBI anticoagulation on venous thromboembolism, hemorrhage, mortality, or coagulation parameters with original analyses were eligible for the review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline was followed throughout the conduct of the review. RESULTS: Thirty-nine eligible studies were identified from the literature, of which 23 studies with complete information on post-TBI anticoagulant use and patient outcomes were summarized in this review. Meta-analysis was unwarranted because of varying methodological design and quality of the studies. Twenty-one studies focused on the effects of pharmacological thromboprophylaxis (PTP) post-TBI on venous thromboembolism and/or progression of intracranial hemorrhage, whereas 2 randomized controlled trials analyzed coagulation parameters as the result of anticoagulation. CONCLUSION: Pharmacological thromboprophylaxis appears to be safe among TBIpatients with stabilized hemorrhagic patterns. More evidence is needed regarding effectiveness of PTP in preventing venous thromboembolism as well as preferred agent, dose, and timing for PTP.
Authors: Andrew Stewart Levy; Kristin Salottolo; Raphael Bar-Or; Patrick Offner; Charles Mains; Michael Sullivan; David Bar-Or Journal: J Trauma Date: 2010-04
Authors: Mary Carlile; David Nicewander; Stuart A Yablon; Allen Brown; Robert Brunner; David Burke; Heechin Chae; Jeffrey Englander; Steve Flanagan; Flora Hammond; Allen Khademi; Lisa A Lombard; Jay M Meythaler; W Jerry Mysiw; Ross Zafonte; Ramon Diaz-Arrastia Journal: J Trauma Date: 2010-04
Authors: Joshua D Arnold; Benjamin W Dart; Donald E Barker; Robert A Maxwell; Hans C Burkholder; Vicente A Mejia; Philip W Smith; Joy M Longley Journal: Am Surg Date: 2010-06 Impact factor: 0.688
Authors: Babak Sarani; Brandy Temple-Lykens; Patrick Kim; Seema Sonnad; Meredith Bergey; Jose L Pascual; Carrie Sims; C William Schwab; Patrick Reilly Journal: J Trauma Date: 2009-11
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2016-04-12 Impact factor: 9.097
Authors: Sarah Hopp; Christiane Albert-Weissenberger; Stine Mencl; Michael Bieber; Michael K Schuhmann; Christian Stetter; Bernhard Nieswandt; Peter M Schmidt; Camelia-Maria Monoranu; Irina Alafuzoff; Niklas Marklund; Marc W Nolte; Anna-Leena Sirén; Christoph Kleinschnitz Journal: Ann Neurol Date: 2016-04-28 Impact factor: 10.422